The POP prevalence for nasal corticosteroids showed an increasing trend during the study period, with an increase of 21% in the overall paediatric population and 59% amongst neonates, although nasal corticosteroids are not labelled for this vulnerable population [ 47 , 52 ].
← all excerpts
Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019.
1
—
—